Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)

• Main Authors: M. M. Loukianov (Author), E. Yu. Andreenko (Author), S. Yu. Martsevich (Author), S. S. Yakushin (Author), A. N. Vorobyev (Author), K. G. Pereverzeva (Author), A. V. Zagrebelnyy (Author), E. Yu. Okshina (Author), V. V. Yakusevich (Author), V. Vl. Yakusevich (Author), E. M. Pozdnyakova (Author), T. A. Gomova (Author), E. E. Fedotova (Author), M. N. Valiakhmetov (Author), V. P. Mikhin (Author), Yu. V. Maslennikova (Author), V. G. Klyashtorny (Author), E. V. Kudryashov (Author), Ju. E. Tatsii (Author), S. A. Boytsov (Author), O. M. Drapkina (Author)
• Format: Book
• Published: Столичная издательская компания, 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom comorbidity, drug therapy, short-term and longterm outc...